Wednesday, March 22, 2023 3/22/2023

Deciphering the impact of sedative choice on the dynamics of Klebsiella pneumoniae lung infection

Award Number: R21AI166098
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By Issue Date FY or Funding FY:

View Award Abstract

Summary Healthcare-associated infections adversely impact patient outcomes and increase healthcare costs by billions of dollars each year. Anesthetic administration is associated with a significantly increased risk of infection via its alterations of immune signaling and immune effector cell function. Despite the increasing recognition that anesthetics modulate immunity, relatively little remains known regarding the breadth of mechanisms by which drugs that target the nervous system influence host immune responses. We have previously demonstrated that brief sedation with propofol, the most commonly used drug for anesthetic induction, dramatically increases host susceptibility to microbial infection. Propofol is widely used for patients requiring intubation and mechanical ventilation, and patients in the ICU can remain sedated with propofol for days. To better define the impact of propofol sedation on respiratory disease, we have developed a mouse model of lung infection using the Gram- negative opportunistic pathogen Klebsiella pneumoniae (Kp). Kp is a growing threat worldwide as a nosocomial pathogen due to its rapid acquisition of antimicrobial resistance; in addition, hypervirulent strains causing community-acquired infections have been recently reported. Preliminary experiments indicate that propofol sedation dramatically increases the severity of Kp disease pathology within the lungs and promotes bacterial dissemination to distal tissues. Using transposon insertion sequencing (INSeq) and libraries of Kp insertion mutants, we have further demonstrated that the choice of sedative influences the selection of Kp mutants that are defective for growth within the infected lung. These results strongly suggest that propofol not only influences the pathology and outcome of lung infection, but that it also differentially impacts the arsenal of bacterial virulence factors required for disease. This proposal is thus designed to explore two related and mutually important hypotheses, those being (1) that propofol increases host susceptibility to microbial (Kp) infection in the lung via alterations in immune signaling that interfere with the recruitment and function of innate immune effector cells; and (2) the choice of sedation alters the lung environment in ways that impact the Kp global virulence repertoire required for bacterial growth in tissues. Aim 1 experiments will determine how sedation choice influences the outcome and progression of Kp lung infection in vivo. Aim 2 will functionally characterize Kp mutants identified based on their virulence being differentially impacted by sedation with propofol versus ketamine/xylazine. Overall, these experiments will provide valuable and important information regarding the impact of sedation on respiratory infection outcome and prognosis.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2023 ( Subtotal = $197,895 )
2023	2023	UNIVERSITY OF ILLINOIS	809 S MARSHFIELD RM 520	CHICAGO	IL	60612	COOK	USA	Allergy and Infectious Diseases Research	000	2	10/28/2022	NON-COMPETING CONTINUATION	$197,895


Issue Date FY: 2022 ( Subtotal = $251,305 )
2022	2022	UNIVERSITY OF ILLINOIS	809 S MARSHFIELD RM 520	CHICAGO	IL	60612	COOK	USA	Allergy and Infectious Diseases Research	000	1	11/16/2021	NEW	$251,305


Grand Total All Awards = $449,200

Sum of Action Amount is $449,200;

Grand Total = $449,200

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Deciphering the impact of sedative choice on the dynamics of Klebsiella pneumoniae lung infection

Award Number: R21AI166098

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer